Home
Business
Corporate Finance
Asset Management
Wealth Management
Global Markets
Structured Finance
Research
Daily Note
Market Strategy
Macroeconomics
Securities Analysis
Customer Trading
Stock Trading
Futures Trading
Options Trading
Virtual Assets Trading
Company News
About CMBI
Company Profile
Join Us
Contact Us
English
Simplified Chinese
Traditional Chinese
English
Home
>
Research
>
Securities Analysis
【行业研究】中国医药 - 海外CXO/生命科学上游1H25业绩剖析:关税影响小于预期,临床CRO订单意外增长 ,普遍上调业绩指引
Click to read the report